Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity
Dietary change leads to a precipitous increase in non-alcoholic fatty liver disease (NAFLD) from simple steatosis to the advanced form of non-alcoholic steatohepatitis (NASH), affecting approximately 25% of the global population. Although significant efforts greatly advance progress in clarifying th...
Main Authors: | Ming Yang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/20/11037 |
Similar Items
-
Preventative and Therapeutic Effects of Astaxanthin on NAFLD
by: Nor Hafiza Sayuti, et al.
Published: (2023-08-01) -
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
by: Stefania De Lorenzo, et al.
Published: (2020-10-01) -
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01) -
Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review
by: Cristina Piras, et al.
Published: (2021-10-01) -
The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
by: Eleni-Myrto Trifylli, et al.
Published: (2022-10-01)